MXPA05004074A - Nuevos adenovirus, acidos nucleicos que los codifican y su uso. - Google Patents
Nuevos adenovirus, acidos nucleicos que los codifican y su uso.Info
- Publication number
- MXPA05004074A MXPA05004074A MXPA05004074A MXPA05004074A MXPA05004074A MX PA05004074 A MXPA05004074 A MX PA05004074A MX PA05004074 A MXPA05004074 A MX PA05004074A MX PA05004074 A MXPA05004074 A MX PA05004074A MX PA05004074 A MXPA05004074 A MX PA05004074A
- Authority
- MX
- Mexico
- Prior art keywords
- protein
- adenovirus expressing
- reverse order
- expressing genes
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/861—Adenoviral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/763—Herpes virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10248039 | 2002-10-15 | ||
| DE10322530 | 2003-05-19 | ||
| PCT/EP2003/005583 WO2003099859A2 (de) | 2002-05-27 | 2003-05-27 | Neue verwendung von adenoviren und dafür codierenden nukleinsäuren |
| DE10324085 | 2003-05-27 | ||
| PCT/EP2003/011427 WO2004035616A2 (de) | 2002-10-15 | 2003-10-15 | Adenovirus mit umgekehrter reihenfolge der expression von genen und verwendung davon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05004074A true MXPA05004074A (es) | 2005-09-20 |
Family
ID=32314683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05004074A MXPA05004074A (es) | 2002-10-15 | 2003-10-15 | Nuevos adenovirus, acidos nucleicos que los codifican y su uso. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8951772B2 (https=) |
| EP (1) | EP1554375B1 (https=) |
| JP (1) | JP4988199B2 (https=) |
| KR (1) | KR101123510B1 (https=) |
| AU (1) | AU2010257327C1 (https=) |
| CA (1) | CA2515650C (https=) |
| DK (1) | DK1554375T3 (https=) |
| MX (1) | MXPA05004074A (https=) |
| PL (1) | PL219321B1 (https=) |
| SG (1) | SG165168A1 (https=) |
| WO (1) | WO2004035616A2 (https=) |
| ZA (1) | ZA200502680B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003222427B8 (en) | 2000-11-17 | 2010-04-29 | Vascular Biogenics Ltd. | Promoters exhibiting endothelial cell specificity and methods of using same |
| US8071740B2 (en) | 2000-11-17 | 2011-12-06 | Vascular Biogenics Ltd. | Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| CN100506284C (zh) | 2001-10-19 | 2009-07-01 | 脉管生物生长有限公司 | 多核苷酸构建体、药物组合物以及靶向的下调血管生成和抗癌的治疗方法 |
| JP5213298B2 (ja) | 2002-05-27 | 2013-06-19 | ホルム，ペル・ゾンネ | アデノウイルスおよびそれをコードしている核酸の新たな使用 |
| CA2546178A1 (en) | 2003-11-14 | 2005-06-09 | Per Sonne Holm | New use of adenovirus and nucleic acids coding therefor |
| EP1689446B1 (de) * | 2003-11-14 | 2015-01-07 | Per Sonne Holm | Neue adenoviren, dafür codierende nukleinsäuren und deren verwendung |
| US20090232800A1 (en) * | 2004-12-31 | 2009-09-17 | Per Sonne Holm | E1-minus adenoviruses and use thereof |
| SG158133A1 (en) * | 2004-12-31 | 2010-01-29 | Sonne Holm | Method for reversing multiple resistance in animal cells |
| KR100747646B1 (ko) | 2005-02-25 | 2007-08-08 | 연세대학교 산학협력단 | 데코린 유전자를 포함하는 유전자 전달 시스템 및 이를 포함하는 약제학적 항종양 조성물 |
| WO2012022496A2 (en) | 2010-08-19 | 2012-02-23 | Per Sonne Holm | Method for killing tumor stem cells |
| KR20210031852A (ko) * | 2018-03-05 | 2021-03-23 | 클리니쿰 레히츠 데어 이자르 데어 테크니쉔 우니베르지테트 뮌헨 | 종양 세포 붕괴성 아데노바이러스와 cdk4/6 억제제의 조합물에 의한 종양의 치료 |
| AU2019294294A1 (en) | 2018-06-25 | 2021-02-11 | Fondazione Telethon Ets | Gene therapy |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE178490T1 (de) * | 1993-02-16 | 1999-04-15 | Onyx Pharmaceuticals | Cytopathische viren zur therapie und prophylaxe der neoplasie |
| US5998205A (en) * | 1994-11-28 | 1999-12-07 | Genetic Therapy, Inc. | Vectors for tissue-specific replication |
| US6254862B1 (en) * | 1997-03-03 | 2001-07-03 | Calydon, Inc. | Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| US6100086A (en) * | 1997-04-14 | 2000-08-08 | Genzyme Corporation | Transgene expression systems |
| DE10015413A1 (de) * | 2000-03-23 | 2001-09-27 | Max Delbrueck Centrum | Mittel zur Diagnose und Therapie viraler Erkrankungen |
| AU2002235141A1 (en) * | 2000-11-27 | 2002-06-03 | Geron Corporation | Glycosyltransferase vectors for treating cancer |
| US20030095989A1 (en) * | 2000-12-18 | 2003-05-22 | Irving John M. | Chimeric cytolytic viruses for cancer treatment |
| EP1346058B1 (de) * | 2000-12-28 | 2007-05-02 | Per Sonne Holm | Adenovirale systeme und deren anwendungen |
| US20030138405A1 (en) * | 2001-04-17 | 2003-07-24 | Juan Fueyo | Conditionally replicative adenovirus to target the Rb and Rb-related pathways |
-
2003
- 2003-10-15 MX MXPA05004074A patent/MXPA05004074A/es active IP Right Grant
- 2003-10-15 KR KR1020057006313A patent/KR101123510B1/ko not_active Expired - Fee Related
- 2003-10-15 CA CA2515650A patent/CA2515650C/en not_active Expired - Fee Related
- 2003-10-15 US US10/531,366 patent/US8951772B2/en not_active Expired - Lifetime
- 2003-10-15 PL PL376573A patent/PL219321B1/pl unknown
- 2003-10-15 WO PCT/EP2003/011427 patent/WO2004035616A2/de not_active Ceased
- 2003-10-15 EP EP03753560.6A patent/EP1554375B1/de not_active Expired - Lifetime
- 2003-10-15 JP JP2005501293A patent/JP4988199B2/ja not_active Expired - Lifetime
- 2003-10-15 DK DK03753560.6T patent/DK1554375T3/en active
- 2003-10-15 SG SG200703426-7A patent/SG165168A1/en unknown
-
2005
- 2005-04-01 ZA ZA2005/02680A patent/ZA200502680B/en unknown
-
2010
- 2010-12-20 AU AU2010257327A patent/AU2010257327C1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200502680B (en) | 2005-11-30 |
| US20060057113A1 (en) | 2006-03-16 |
| KR20050061530A (ko) | 2005-06-22 |
| EP1554375B1 (de) | 2018-08-22 |
| EP1554375A2 (de) | 2005-07-20 |
| KR101123510B1 (ko) | 2012-04-12 |
| JP4988199B2 (ja) | 2012-08-01 |
| US8951772B2 (en) | 2015-02-10 |
| WO2004035616A3 (de) | 2004-05-27 |
| CA2515650C (en) | 2019-10-01 |
| AU2010257327C1 (en) | 2012-02-16 |
| PL376573A1 (pl) | 2006-01-09 |
| AU2010257327A1 (en) | 2011-01-13 |
| PL219321B1 (pl) | 2015-04-30 |
| DK1554375T3 (en) | 2018-12-17 |
| CA2515650A1 (en) | 2004-04-29 |
| JP2006518589A (ja) | 2006-08-17 |
| WO2004035616A2 (de) | 2004-04-29 |
| AU2010257327B2 (en) | 2011-09-29 |
| SG165168A1 (en) | 2010-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0510475B8 (pt) | adenovírus quimérico recombinante, uso do mesmo no tratamento de câncer e métodos de inibição de crescimento de uma célula de câncer, de fornecimento de uma proteína terapêutica a uma célula e para o isolamento do adenovírus | |
| MXPA05004074A (es) | Nuevos adenovirus, acidos nucleicos que los codifican y su uso. | |
| ATE310829T1 (de) | Zelllinien und konstrukte für die herstellung von e1-deletierten adenoviren in abwesenheit von replikationskompetentem adenovirus | |
| WO2005065418A3 (en) | Compositions and methods of use of targeting peptides for diagnosis and therapy | |
| CY1108459T1 (el) | Ακτ-3 νουκλεϊκα οξεα, πολυπεπτιδια, και χρησεις αυτων | |
| WO2003099859A3 (de) | Neue verwendung von adenoviren und dafür codierenden nukleinsäuren | |
| WO2004031357A3 (en) | Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors | |
| DE69926251D1 (de) | Verfahren zum vernichten von tumoren und tumor-assoziierten endothelialzellen mit adenoviralen mutanten | |
| CA2478616A1 (en) | Use of adenoviruses mutated in the va genes for cancer treatment | |
| CA2449013A1 (en) | Viral mutants that selectively replicate in targeted human cancer cells | |
| WO1999046371A3 (en) | Induction of apoptotic or cytotoxic gene expression by adenoviral mediated gene codelivery | |
| BR0212070A (pt) | ácidos nucléicos e polipeptìdeos bv8 com atividade mitogênica | |
| BG105779A (bg) | Човешки антибиотични протеини | |
| DE60237013D1 (de) | Replizierende adenovirus-vektoren | |
| AU2003259761A1 (en) | Enhancement of adenoviral oncolytic activity in prostate cells by modification of the e1a gene product | |
| DK1224310T3 (da) | Fremstilling af rekombinante adenovira og adenovirale banker | |
| WO2004018002A3 (en) | Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells | |
| WO2001072341A3 (en) | Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation | |
| FR2835429B1 (fr) | Utilisation d'acide ascorbique pour renforcer la cohesion de la jonction dermo-epidermique | |
| WO2003077841A3 (en) | Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases | |
| WO2004043406A3 (en) | ENGINEERED RNAi ADENOVIRUS SILENCING EXPRESSION (ERASE) OF DNA REPAIR PROTEINS | |
| EP1607483A4 (en) | RECOMBINANT PRODUCT CONSTRUCTED FROM A VIRAL VECTOR AND A HUMAN TUMOR SUPPRESSOR GENE AND USE OF THE RECOMBINANT PRODUCT | |
| WO2002042325A3 (en) | Cyp1b1 nucleic acids and methods of use | |
| EP2172552A3 (en) | Recombinant nucleic acids comprising regions of AD6 | |
| RU2351361C2 (ru) | Новое применение аденовируса и кодирующих его нуклеиновых кислот |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |